Born from a 2013 University of Helsinki research idea, The Solubility Company became a 2018 university spin-out providing preclinical measurement services to pharmaceutical and biotechnology researchers. Its laboratories in Helsinki and Quakertown use proprietary machine vision to study how materials dissolve, even from very small samples, giving development teams earlier insight into drug formulation and solid form.
LonzaFounded in Switzerland in 1897, Lonza is a global contract development and manufacturing organization that helps pharmaceutical and biotechnology companies turn new medicines into clinical and commercial therapies. Its network of more than 30 sites and approximately 19,000 employees spans five continents, with capabilities ranging from biologics and small-molecule drug products to cell and gene therapies and mRNA manufacturing. In Bend, Oregon, the former Bend Research team brings more than 45 years of specialized experience in improving drug solubility and bioavailability.WALKERSVILLE, MD
Ajinomoto Bio-Pharma ServicesWith more than 40 years in small-molecule manufacturing, Ajinomoto Bio-Pharma Services develops and produces pharmaceutical APIs and intermediates for drug companies worldwide. Its CDMO capabilities span the path from preclinical work through commercialization, while on-site analytical laboratories characterize molecules and support quality testing throughout their life cycle. Through Forge Biologics, a member of Ajinomoto Bio-Pharma Services, the company also provides AAV and plasmid manufacturing from preclinical through commercial stages.COLUMBUS, OH
iCeuticaiCeutica develops improved branded medicines with pharmaceutical partners and from its own pipeline, using its proprietary SoluMatrix™ Fine Particle Technology to make drug particles 10 to 200 times smaller than conventional particles. The scalable process is designed to address bioavailability, dose consistency, side effects and drug delivery, and has supported three FDA-approved products launched in the United States. Based in Princeton with an Australian registered office, iCeutica has applied the technology across pain and inflammation, oncology and respiratory disease programs.KING OF PRUSSIA, PA
Spheryx, IncFounded by physicists Laura Philips and David Grier, Spheryx develops particle-characterization instruments and analytical services built around its patented Total Holographic Characterization® technology. Its xSight system measures suspended particles in complex fluids while distinguishing particles of similar size by composition, giving researchers and manufacturers a closer look at formulations such as biologics and wastewater. The company’s scientific leadership combines holographic microscopy expertise with experience in soft matter, optics and biopharmaceutical applications.NEW YORK, NY